The cholecystokinin (CCK) analog JMV-180 acts as a partial agonist in rats and a full agonist in mice. Whether this functional variability is due to species differences in CCK receptor structure or to alterations in the cellular environment is unknown. To address this question, an adenoviral construct encoding the rat CCK A receptor (AdCCK A R) was used to express the rat receptor in acini from CCK A receptor-deficient mice (CCK A R ؊/؊). Infection of CCK A R ؊/؊ acini in vitro with pAdCCK A R led to a time-dependent increase in 125 I-CCK 8 binding. The affinity for JMV-180 of the adenovirally transferred rat and the endogenous mouse CCK A receptors was not different. In native mouse acini, JMV-180 acted as a full agonist (both stimulation and inhibition of amylase release). In contrast, in mouse acini expressing pAdCCK A R JMV-180 acted as a partial agonist (only stimulation of amylase release). In addition, the pattern of protein synthesis induced by JMV-180 in CCK A R ؊/؊ mouse acini infected with AdCCK A R resembled the pattern observed in wild-type rats (lack of inhibition) rather than the respective pattern in wild-type mice (inhibition). These data suggest that species differences in the CCK A receptor of rats and mice account for the observed divergence in the acinar cell response to JMV-180.
Gene transfer studies provide a powerful approach to investigate the correlation between receptor structure and function. Manipulation of the cDNA encoding a receptor followed by expression of the mutant protein in a cell model allows detailed analysis of the role of specific receptor domains and individual residues. This approach has been widely utilized and has resulted in important advancement in our understanding of G protein-coupled receptor signaling (1) . However, it has become increasingly apparent that the choice of cell model used for gene transfer experiments significantly impacts the receptor properties that are observed (2) . Differentiated cells express specific subsets of proteins that interact with G protein-linked receptors; examples include G proteins, arrestins, G protein receptor kinases, and RGS proteins (3) . The cell model may therefore exert a major influence on the outcome of receptor structure-function studies.
Recently it was suggested that interspecies variation in cellular milieu might explain observed differences between the drug-induced responses of the rat versus the mouse CCK A receptor (4) . In both species, CCK A receptors bind the endogenous hormone cholecystokinin (CCK) 1 with high affinity. A similar pattern of cell signals and biological responses is in turn triggered in both rats and mice. In contrast, the CCK analog JMV-180 acts as a partial agonist in the rat and a full agonist in the mouse (5) (6) (7) . Differences between partial and full CCK agonists are striking in the pancreatic acinar cell. Full agonists (e.g. CCK-8) show marked differences in biological effects at both physiologic and supra-physiologic concentrations. At physiologic concentrations, full agonists cause increases in acinar cell secretion, an oscillatory pattern of intracellular Ca 2ϩ concentration, stimulation of protein synthesis, and little measurable increase in either inositol 1,4,5-trisphosphate or diacylgycerol. In contrast, high concentrations of full agonists cause an inhibition of acinar cell secretion, a peak and plateau pattern of intracellular Ca 2ϩ concentration, inhibition of protein synthesis, and large increases in inositol 1,4,5-trisphosphate and diacylgycerol. In mice, JMV-180, like CCK-8, is a full agonist and shows a similar pattern of biphasic responses (5) . In contrast, when administered to rats, JMV-180 lacks the biphasic response and only generates the pattern observed with low concentrations of CCK-8 (5, 8) .
The explanation for this interspecies variability is not clear. There are 23 amino acid differences between the rat and mouse CCK A receptor sequences. Therefore, one possibility is that interspecies polymorphisms in the CCK A receptor structure account for the observed functional variability in the action of JMV-180. An alternative explanation for the observed species dependence of JMV-180 signaling is that there are significant differences between acinar cells in rats and mice. A recent study supporting the latter hypothesis showed that there were no major differences between the binding or coupling of rat and mouse CCK A receptors when the receptors were expressed in CHO cells (4) . However, CHO cells are fibroblastic cells derived from the Chinese hamster ovary and may not accurately reflect the cellular context of a pancreatic acinar cell.
The initial goal of the current study was to express a functional rat CCK A receptor in a mouse acinar cell and examine the responses to CCK-8 and JMV-180 in order to determine whether the physiologic cellular context influences the observed differences in agonist activity. We utilized adenoviralmediated gene transfer to express rat CCK A receptors in pancreatic acini, because we have previously found this to be a highly efficient approach (9) . To avoid complications due to the presence of endogenous mouse CCK A receptors, we utilized acini prepared from CCK A receptor-deficient mice (CCK A R Ϫ/Ϫ) (10). We found that adenoviral infection allowed expression of ectopic receptors to physiologic levels in nearly 100% of the cells within a few hours. At the titers utilized in this study, adenovirally infected acini secreted amylase and synthesized protein identically to uninfected acini. Using this approach we observed that ectopically expressed rat CCK A receptors mimicked the pattern of biological responses (i.e. secretion and protein synthesis) to CCK-8 and JMV-180 that is found in studies of wild-type rat acini. These results contrast with what was observed with endogenous mouse CCK A receptors. Taken together, these data indicate that CCK A receptor structural differences account for the divergence in JMV-180 activity in these two species and, furthermore, illustrate the importance of investigating receptor function in the context of physiologically relevant cell models.
EXPERIMENTAL PROCEDURES
Materials-Harlan Sprague-Dawley rats were obtained from Harlan Inc. (Indianapolis, IN). CCK A R Ϫ/Ϫ mice were generated as described previously (11) . 129/SVIMJ control mice were purchased from The Jackson Laboratory (Bar Harbor, Maine). Fura 2-AM was purchased from Molecular Probes (Eugene, OR). Collagenase (CLSPA grade) was purchased from Worthington Biochemicals (Freehold, NJ (12) . Briefly, a HindIII/BamHI fragment that encoded the full-length rat CCK A receptor (13) (kindly provided by S. A. Wank, National Institutes of Health, Bethesda, MD) was blunted with Klenow and cloned into the EcoRV site of the pAd-Track-CMV shuttle vector, producing pAd-Track-CMV-CCK A R plasmid. Under the control of distinct CMV promoters, this plasmid expresses the rat CCK A receptor and, in parallel, green fluorescent protein (GFP). The construct was linearized with PmeI and cotransfected together with the adenoviral backbone vector, pAdEasy-1, into Escherichia coli strain BJ5183. Recombinant cosmids were selected with kanamycin and screened by BamHI and PacI digestion. The adenoviral construct was then cleaved with PacI and transfected in a packaging cell line (human embryonic kidney 293 cells). An adenovirus (AdLacZ) expressing bacterial ␤-galactosidase and GFP, each under the control of a separate CMV promoter, was a gift from Dr. He (John Hopkins Oncology Center, Baltimore, MD) and utilized as a control. The recombinant virus was concentrated using a CsCl gradient. The titer of the viral stocks was estimated based on the density of GFP-expressing cells. Virus was stored in 10% glycerol at Ϫ80°C in aliquots of 50 l.
Preparation of Acini and Infection with the Virus-Acini were prepared by methods previously described (14) . In brief, the pancreas was excised from freely fed adult male Harlan Sprague-Dawley rats or 129/SVIMJ mice. Acini were prepared by enzymatic digestion with purified collagenase, followed by mechanical shearing. Acini were then filtered through 150-m Nitex mesh, purified by sedimentation through 4% bovine serum albumin in Dulbecco's modified Eagle's medium. The acini were suspended in HEPES-Ringer buffer (HR) containing 1% bovine serum albumin, 0.1 mg/ml soybean trypsin inhibitor, and 127 mM NaCl, 4.7 mM KCl, 1.06 mM MgCl 2 , 1.28 mM CaCl 2 , 1.0 mM Na 2 HPO 4 , 10 mM HEPES, 2 mM L-glutamine, and 10 mM D-glucose and essential amino acids. The pH was adjusted to 7.4 and equilibrated with 100% O 2 before use. The acini of CCK A R Ϫ/Ϫ mice were infected with virus encoding the rat CCK A R. Acini of wild-type mice and rats were infected with virus encoding ␤-galactosidase. All virus was used at ϳ10 7 plaque-forming unit/mg of protein. Virus was added to acini in 3 ml of HR buffer for 10 min. The acini were then diluted with HR to 13 ml, transferred to 100-mm dishes, and incubated at 37°C in a humidified 5% CO 2 atmosphere.
JMV-180 Competition Binding Assays-The affinity of JMV-180 for acini expressing CCK A Rs was assessed by competition binding experiments using 5 pM 125 I-CCK-8 as radioligand. All experiments were done in HR buffer with the bovine serum albumin concentration adjusted to 0.1% and inclusion of 0.5 mg/ml bacitracin. Acini were incubated in polystyrene tubes at 37°C with increasing amounts of nonradioactive JMV-180 for 90 min; preliminary studies showed that binding reached a steady-state by 90 min. Nonspecific binding was assessed in the presence of 100 nM unlabeled CCK-8. Acini were separated from unbound CCK by centrifugation at 300 ϫ g for 3 min and then washed twice with ice-cold 0.9% NaCl. The cells were then solubilized with 1 ml of 0.1 N NaOH, and radioactivity was quantified in a ␥-counter. Protein content was determined on samples after counting. Binding affinity was calculated from JMV-180 competitive binding experiments using the Graphpad Prism 3.0 program (Graphpad Software Inc, San Diego, CA).
Analysis of CCK and JMV-180 Induced Increases in Intracellular Ca
2ϩ Concentration-Analysis of intracellular Ca 2ϩ concentration was conducted using ratiometric imaging of Fura-2-loaded cells as described previously (15) . In brief, acini were incubated with 5 M fura 2-AM at 37°C for 30 min and then washed and resuspended in HR buffer. Fura-loaded acini were transferred to a closed chamber, mounted on the stage of a Zeiss Axiovert inverted microscope, and continuously superfused at 1 ml/min with HR buffer and different concentrations of CCK-8 or JMV-180 at 37°C. Measurement of emitted fluorescence and calibration of these signals to yield a measurement of intracellular Ca 2ϩ were performed using an Attofluor digital imaging system (Rockville, MD), as described previously (15) .
Analysis of Amylase Secretion-Amylase secretion in response to CCK-8 or JMV-180 was measured as described previously (9) . Briefly, acini were washed and resuspended in HR at ϳ1 mg/ml. Aliquots of 3.5 ml were distributed into 25-ml polycarbonate Erlenmeyer flasks and incubated with increasing concentrations of CCK-8 or JMV-180 at 37°C for 30 min. Incubation was terminated by centrifugation of 1-ml aliquots for 15 s at 15,000 ϫ g. The concentration of amylase in the medium was measured using the Amylase 3 reagent. Results were expressed as a percentage of initial acinar amylase content.
Incorporation of Amino Acid into Protein-The effects of CCK-8 and JMV-180 on protein synthesis were examined using [
3 H]leucine as described previously with minor modifications (16) . Briefly, 1-ml aliquots of acinar suspension (1 mg of total protein) were preincubated at 37°C for 30 min with either CCK-8 or JMV-180 using duplicate flasks for each concentration studied. [ 3 H]Leucine (2 Ci/ml) was then added, and incorporation was terminated 20 min later by diluting with an equal volume of ice-cold 0.9% NaCl containing 20 mM unlabeled leucine. After centrifugation, the sediments were washed with 4°C saline and disrupted by sonication in 0.75 ml of distilled water. The protein was then precipitated with equal volumes of ice-cold 20% trichloroacetic acid. After 30 min, the trichloroacetic acid precipitates were washed twice with ice-cold 10% trichloroacetic acid and dissolved in 400 l 0.1 N NaOH. Aliquots were removed for protein assay, and the remaining samples were measured in a liquid scintillation counter. Data for each experimental condition were normalized to the percentage of
3 H]leucine added/mg of protein ϫ 100). Statistical Analysis-Statistical analysis was carried out using Graphpad Prism 3.0 program (Graphpad Software Inc, San Diego, CA). Differences between individual conditions and controls were tested with analysis of variance and the Newman-Keuls multiple range test. Twoway analysis of variance was used to analyze the experiments that had a factorial design. In the analysis, differences were considered significant when p Ͻ 0.05.
RESULTS

Adenoviral-mediated Expression of a Rat CCK A Receptor-
CCK A receptors are expressed in the exocrine pancreas of both rats and mice. Species differences in the structure of these receptors are relatively minor, with only 23 amino acids that diverge between respective CCK A R homologs (Fig. 1) . The major structural difference is a seven-amino acid insertion found in the third intracellular loop of the mouse CCK A receptor. Dissimilarities have previously been noted between the functional effects of the CCK analog JMV-180 in these two species (5, 6) . To determine whether these divergent biological responses were the result of variability in the structure of the receptors or due to differences in cellular environment, we utilized an adenoviral construct encoding the rat CCK A receptor (AdCCK A R). This virus also expresses GFP under the control of a distinct CMV promoter. In initial experiments, efficiency of the infecting virus was assessed by monitoring GFP levels in acini by fluorescence microscopy. It was observed that adenoviral-mediated gene expression was titer-dependent (data not shown). Using a titer of ϳ10 7 plaque-forming unit/mg of acinar protein, nearly 100% of the acini expressed GFP (Fig. 2) . Higher titers did not further improve efficiency (data not shown).
Adenoviral-mediated gene expression was also time-dependent. To define the level of receptor expression, 125 I-CCK binding was assessed at different times after infection with AdC-CK A R. Acini isolated from CCK A R Ϫ/Ϫ mice showed no CCK binding before infection. After infection of CCK A R Ϫ/Ϫ acini with AdCCK A R, a time-dependent increase in 125 I-CCK binding was observed (Fig. 3) . Specific binding levels comparable with those of acini from CCK A R ϩ/ϩ mice were observed ϳ4 h after infection. Maximal binding levels ϳ5-fold over control were observed after 16 h. Therefore, all biological responses were assessed 4 h post-infection.
Binding and Signaling of the Rat CCK A Receptor Expressed in Mouse Acini-To determine the affinity of the rat CCK A receptor expressed in the mouse acinar cells, competition binding experiments were performed after infection of acini from CCK A R Ϫ/Ϫ mice with AdCCK A R. When expressed in acini from CCK A R Ϫ/Ϫ mice, the rat receptor showed high affinity displaceable 125 I-CCK binding that was comparable with affinities observed with either mouse or rat wild-type acini (data not shown). JMV-180 competed for binding of 125 I-CCK (Fig. 4) . The affinity of JMV-180 for the rat receptor expressed in the mouse CCK A R Ϫ/Ϫ acinar cell was not significantly different from the affinity of the native mouse receptor assessed in acini from CCK A R ϩ/ϩ mice (K i ϭ 1.4 Ϯ 0.1 versus 1.5 Ϯ 0.39 nM, n ϭ 4, p Ͼ 0.05). Infection with control adenovirus had no effect on receptor binding (data not shown).
To characterize the coupling of the rat CCK A R to calciummediated signaling when expressed in mouse acini, cells were loaded with Fura-2AM, and intracellular Ca 2ϩ levels were determined by ratiometric fluorescence imaging. CCK A R Ϫ/Ϫ acini without virus infection did not respond to CCK-8 (Fig. 5A) or JMV-180 (data not shown); however, they did show a normal response to stimulation with bombesin. Acini from CCK A R Ϫ/Ϫ mice infected with AdCCK A R showed an oscillatory pattern of Ca 2ϩ increase after stimulation with a low concentration and a peak and plateau type of response when stimulated with a high concentration of CCK-8 (Fig. 5B) . The response of AdCCK A Rinfected acini to CCK-8 was similar to the pattern previously observed in acini prepared from CCK A R ϩ/ϩ mice or from rats (5). Responses to JMV-180 were not markedly different between acini prepared from wild-type rats and mice. Both showed oscillatory Ca 2ϩ responses (Fig. 5, C and E) . However, subtle differences were noted. In mice, the oscillations did not return to base line, whereas in rats the oscillations did return to base-line levels. Ca 2ϩ responses to JMV-180 of acini from CCK A R Ϫ/Ϫ mice infected with AdCCK A R resembled the oscillatory activity observe with wild-type rat acini, i.e. with a full return to base line between spikes. It should be noted that these differences in Ca 2ϩ signaling were somewhat variable and did not allow a clear distinction between species.
Biological Responses to Activation of Rat CCK A Receptors Expressed in Mouse Acini-To assess the biological activity of mouse acini expressing recombinant rat CCK A receptors we analyzed the effect of receptor activation on both amylase secretion and protein synthesis. In initial experiments, the effect of adenoviral infection per se on pancreatic acinar cell amylase secretion was determined. Infection of acini isolated from CCK A R ϩ/ϩ mice with a control GFP-expressing virus had no significant effect on basal (1.0 Ϯ 0.4 versus 1.8 Ϯ 0.4% total/30 min, n ϭ 3, p Ͼ 0.05) or maximal (5.2 Ϯ 1.9 versus 5.1 Ϯ 1.1% total/30 min, n ϭ 3, p Ͼ 0.05) CCK-8 stimulated amylase release. Next, the concentration-dependent release of amylase stimulated with either CCK-8 or JMV-180 was assessed. Acini from CCK A R Ϫ/Ϫ mice were compared with acini from control mice and control rats (Fig. 6) . In both rat and wild-type mice acini, a typical biphasic dose-response curve for CCK-8 stimulation of amylase release was observed. The percentage of total amylase released in 30 min was less in mice (Fig. 6A ) than in rats (Fig. 6C) , as has been reported previously (17) . In both species, concentrations of CCK-8 above 1 nM caused a reduction in amylase release. By contrast, markedly different patterns of response to stimulation with JMV-180 were observed in rats versus CCK A ϩ/ϩ mice. In CCK A ϩ/ϩ mice, JMV-180 caused a biphasic stimulation of amylase release, with prominent inhibition observed at supramaximal concentrations (Fig. 6A) . In rats, JMV-180 showed monophasic concentration dependence without causing any decrease of amylase release even at supramaximal concentrations (Fig. 6C ). In acini from CCK A R Ϫ/Ϫ mice infected with AdCCK A R the amylase response pattern to CCK-8 was biphasic, similar to that observed in acini from control rats and mice. The level of amylase released was comparable with what was observed in native mouse acini. However, in mouse acini expressing the rat CCK A receptor, the pattern of amylase release stimulated by JMV-180 was similar to that observed in control rats (monophasic) rather than control mice (biphasic). Although JMV-180 stimulated amylase secretion at low concentrations in rat AdCCK A R-infected mouse acini, no inhibition of secretion was observed even at concentrations up to 1 M (Fig. 6B) .
To evaluate the effect of receptor activation on protein synthesis, the incorporation of [ 3 H]leucine into protein was analyzed. Differences were noted in the effects of both CCK-8 and JMV-180 on protein synthesis in rats versus mice. In control mice, CCK-8 caused an inhibition of protein synthesis that was significant at a concentration of 0.1 nM (Fig. 7A) . In rat acini, CCK-8 inhibited protein synthesis, but these effects required CCK-8 concentrations above 1 nM (Fig. 7C) . In control mice, JMV-180 caused a decrease in protein synthesis (Fig. 7A) . In contrast, in rat acini, JMV-180 did not inhibit protein synthesis even at concentrations up to 1 M (Fig. 7C) . The pattern of effects of CCK-8 and JMV-180 on protein synthesis in acini isolated from CCK A Ϫ/Ϫ mice infected with AdCCK A R resembled the observed pattern in the rat. In mouse acini expressing ectopic rat CCK A receptors, CCK-8 did not significantly inhibit protein synthesis at concentrations below 1 nM (Fig. 7B) . In addition, as in rat acini, JMV-180 did not inhibit protein synthesis at any concentration. Overall, the mouse CCK A R Ϫ/Ϫ acini expressing rat CCK A Rs biologically resembled wild-type rat rather than wild-type mouse acini.
DISCUSSION
In this study we expressed rat CCK A receptors in the context of the mouse pancreatic acinar cell. Although the mouse CCK A receptor and the rat CCK A receptor are structurally highly homologous, several important differences in ligand-induced activity were observed. Activation of the mouse CCK A receptor with the CCK-8 analog JMV-180 had a biphasic effect on secretion, as has been previously noted (5). However, activation of the rat CCK A receptor in the context of the mouse acini did not show high dose inhibition. This pattern of response is similar to what is observed in wild-type rat acinar cells (5) . Furthermore, activation of the mouse CCK A receptor with JMV-180 inhibited protein synthesis, as has been previously described (5) . In contrast, no inhibitory effect was noted when the rat CCK A receptor was activated in the context of the mouse acinar cell. Thus, the rat CCK A receptor expressed in the context of the mouse acinar cell responds similarly to what is observed in wild-type rat acini and contrasts with the CCK A R-induced effects observed in wild-type mouse acini. Therefore, structural differences in the CCK A R protein are the most likely explanation for the observed divergence in effects of JMV-180 between the two species.
This study utilized adenoviral-mediated gene transfer to express receptors in pancreatic acini. Adenoviral infection has been shown to be a highly efficient means of gene transfer to this cell type (9, 14, 18 ). In the current study using GFP expression to monitor gene transfer, we observed nearly 100% efficiency. This high level was confirmed in experiments imaging Ca 2ϩ release in individual acinar cells, where every cell infected with receptor bearing adenovirus showed a response to CCK-8. Adenoviral infection at the titers used in the current study did not perturb receptor binding, Ca 2ϩ signaling, secretion, or protein synthesis. However, previously we noted that adenoviral infection induces an increase in NF-B activation (14) . Furthermore, at titers higher than those utilized in the current study, significant deleterious effects were noted (data not shown). Therefore, adenoviral titer is a critical parameter in this type of study. To avoid the complications of altering viral titers we utilized time as a means of controlling receptor expression levels. Receptor levels were observed to increase rapidly after infection, and levels that approximated those found in control acini were observed within 4 h. The biological response observed with adenovirus-mediated receptor expression approximated the biology observed in control cells, illustrating the power of this approach for the study of receptor function.
CCK-8 stimulates an identical pattern of response in both species as well as in mouse acini recombinant rat CCK A receptors. In both species, the CCK A receptor is thought to mediate its signaling through interactions with heterotrimeric G proteins of the G q family (19, 20) . An interesting aspect of CCK receptor activation is the dependence on agonist concentration for coupling to separate intracellular signaling events that in turn lead to different biological outcomes (21) . At low physiologic concentrations, CCK-8 stimulates an oscillatory Ca 2ϩ response (22) , stimulates secretion and protein synthesis (21) , and increases Erk activity (23) . However, at high concentrations, CCK-8 inhibits secretion and protein synthesis (5), disrupts the cytoskeleton (24), activates stress responses includ- ing activation of Jun kinase (25) and NFB (14) , and induces an acute edematous pancreatitis (26) . Thus, the nature of the signaling pathways that differentiate between the effects of high and low concentrations of CCK is potentially of great significance.
The JMV-180 analog is a useful tool in the investigation of CCK receptor signaling. JMV-180 is a synthetic analogue of the COOH-terminal heptapeptide of CCK, with the structure t-butoxycarbonyl-Tyr(SO 3 )-Nle-Gly-Trp-Nle-Asp-2-phenylethyl ester (8) (Nle is norleucine). The most important modification in this CCK analog is in the carboxyl terminus, where aspartate is linked by an ester bond to phenylamine instead of the peptide bond linkage to the terminal-amidated phenylalanine in CCK. Other modifications in this molecule confer increased stability but likely do not affect biological activity (27). In the rat JMV-180 acts as a partial agonist. Activation of the rat CCK A receptor with JMV-180 elicits biological responses associated with the low concentrations of CCK but not with high concentrations (7) . Therefore, JMV-180 has become a popular tool for differentiating between the effects of low and high concentrations of CCK in the rat. In contrast, in the mouse JMV-180 acts as a full agonist, activating the complete range of signaling mechanisms associated with the CCK A receptor (5).
One possible explanation for the species difference in the effects of JMV-180 is that mouse and rat pancreatic acinar cells present a different environment to the CCK A receptor. Little is know about the patterns of expression of proteins important to receptor signaling in these cells. Based on work in other cell types, it is well established that receptor function is influenced by a variety of cellular proteins including heterotrimeric G proteins, G protein-linked receptor kinases, arrestins, and RGS proteins (3). Unfortunately, little is known concerning the identity and qualitative distribution of these regulatory molecules within pancreatic acinar cells. However, acinar cells are highly differentiated and specialized for the synthesis, storage, and secretion of digestive enzymes. In this regard, cells from rats and mice share more similarities with each other than with most other cell types. Activation of receptors in the context of the rat acinar cell caused the release of a greater percentage of total cellular amylase content than did activation of either rat or mouse CCK A receptors in the acini prepared from mice. This species difference has been previously noted (17) . Despite these intracellular differences, activation of the rat CCK A receptor in the context of the mouse acini gave a pattern of effects identical to what is observed in rat acini. Therefore, fundamental differences in receptor structure rather than the cellular environment per se most likely explain the observed differences in JMV-180 effects in rats versus mice.
No appreciable differences were observed in the effects of JMV-180 when the rat and mouse CCK A receptors were expressed in CHO cells (4) . This suggests that the context of the pancreatic acinar cell is required to unravel functional differences between rat and mouse CCK A receptors. One limitation of the previous study in CHO cells was that it is not possible to investigate the effects of receptor activation on secretion in this model. The only biological response analyzed in the CHO cells was Ca 2ϩ release, and no differences between rat and mouse CCK A receptor stimulation were noted. However, it is possible that the differences between rats and mice in this parameter are small. We observed only subtle differences between the effects of JMV-180 on Ca 2ϩ release in rats and mice. In rats, the response to a supramaximal concentration of JMV-180 was exclusively oscillatory, as has been reported previously (22) . In mice, the response was also oscillatory in nature, but at least initially, the oscillations did not return to base line. It is of note that activation of the rat CCK A receptor in the context of the mouse acinar cell produced a pattern of Ca 2ϩ release that was more similar to the rat than to the control mouse, although the observed differences were subtle and difficult to quantify. It is possible that differences in the effects of JMV-180 on rat versus mouse CCK A receptors on CHO cells might be detectable if other cellular parameters, such as protein synthesis, were measured.
In conclusion, expression of the rat CCK A receptor in the context of receptor-deficient mouse pancreatic acinar cells indicates that differences in receptor structure contribute to the divergent effects of JMV-180 between species. The pattern of responses to JMV-180 activation of rat CCK A receptors expressed in the context of the mouse pancreatic acinar cell was entirely compatible with what is observed in wild-type rat pancreatic acinar cells and clearly different than what is observed in wild-type mouse acini. Therefore, these data indicate that differences in CCK A receptor structure between rats and mice lead to distinctive interactions with JMV-180 and explain the observed species dependent differences in biological activity.
